Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment
ImmunoTargets and Therapy · 2024-10 · Volume 13 · 571-583
DOI: 10.2147/itt.s483093 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2024-10. Verfasst von Xiaoling Shang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Cancer Hospital and Institute, Shandong University, Jinan, 250117, People's Republic of China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shandong Cancer Hospital and Institute, Shandong University, Jinan, 250117, People's Republic of China.
- Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai Medical College, Shanghai, People's Republic of China.
- Department of Clinical Drug Research, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, People's Republic of China.
- Department of Radiation Oncology, Qilu Hospital of Shandong University, Shandong University, Jinan, 250117, People's Republic of China.
- Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, People's Republic of China.
ORCID-Profile: Haiyong Wang
Zitieren
APA
Shang, X., Zhang, C., Lv, Y., Zhang, X., Guo, K., Li, H., & Wang, H. (2024). Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment. ImmunoTargets and Therapy, Volume 13, 571-583. https://doi.org/10.2147/itt.s483093
Vancouver
Shang X, Zhang C, Lv Y, Zhang X, Guo K, Li H, et al. Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment. ImmunoTargets and Therapy. 2024;Volume 13:571-583. doi:10.2147/itt.s483093
BibTeX
@article{Shang2024,
author = {Shang, Xiaoling and Zhang, Chenyue and Lv, Yuanyuan and Zhang, Xiaoxiao and Guo, Kaiyue and Li, Huijuan and Wang, Haiyong},
title = {Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment},
journal = {ImmunoTargets and Therapy},
year = {2024},
volume = {Volume 13},
pages = {571--583},
doi = {10.2147/itt.s483093}
}
EUVIMED